سعر Mylotarg 500mg/100ml vial for i.v. inf. 2026

Mylotarg 500 mg/100 ml vial for intravenous infusion (Vodachem; manufactured by Pharmacell, Egypt): levofloxacin 500 mg in 100 ml, a fluoroquinolone antibacterial. Not to be confused with Pfizer's Mylotarg (gemtuzumab ozogamicin), a different product with the same brand name.

• Respiratory tract infections, skin and skin structure infections, urinary tract infections, surgical prophylaxisPopulation: Not statedVodachem Pharmaceuticals (marketing company website)
• Nosocomial pneumonia; community-acquired pneumonia; complicated and uncomplicated skin and skin structure infections; chronic bacterial prostatitis; inhalational anthrax (post-exposure); plague; complicated UTI and acute pyelonephritis; uncomplicated UTI, acute bacterial exacerbation of chronic bronchitis and acute bacterial sinusitis (reserve for patients without alternatives)Population: Adults; paediatric patients >= 6 months only for anthrax and plagueDailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to levofloxacin or other quinolone antibacterials.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: disabling and potentially irreversible serious reactions (tendinitis and tendon rupture, peripheral neuropathy, CNS effects); may exacerbate myasthenia gravis; reserve for patients without alternatives for uncomplicated UTI, acute bacterial exacerbation of chronic bronchitis and acute bacterial sinusitis.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Hypersensitivity reactions, hepatotoxicity, aortic aneurysm and dissection, Clostridioides difficile-associated diarrhoea, QT prolongation, blood glucose disturbances, photosensitivity and development of resistant bacteria.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Solutions containing multivalent cations (e.g. magnesium)Do not co-administer through the same IV line.DailyMed (U.S. National Library of Medicine)
• WarfarinEnhanced anticoagulant effect reported; monitor INR.DailyMed (U.S. National Library of Medicine)
• Antidiabetic agentsBlood glucose disturbances (hypo- and hyperglycaemia); monitor glucose.DailyMed (U.S. National Library of Medicine)

• No adequate and well-controlled studies in pregnant women; not teratogenic in rats or rabbits; use in pregnancy only if the potential benefit justifies the potential risk to the fetus.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Presumed to be excreted in human milk; because of potential serious adverse reactions in nursing infants, decide whether to discontinue nursing or the drug.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Levofloxacin: Inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV.